Bruton’s tyrosine kinase (BTK) is a mediator of B-cell receptor pathway activation associated with nuclear factor-κB pathway activation in diverse B-cell lymphomas. This evidence concerns the gene BTK and B-cell non-Hodgkin lymphoma.